U.S. Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, Dental, Skin & Integumentary, Urology, Neurology), And Segment Forecasts, 2024 - 2030
- Report ID: GVR-4-68040-244-9
- Number of Pages: 80
- Format: Electronic (PDF)
- Historical Range: 2018 - 2023
- Industry: Healthcare
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in U.S.
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Outlook
2.3. Competitive Insights
Chapter 3. U.S. Tissue Engineering Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in stem cell technology & tissue engineering
3.2.1.2. Rise in the number of clinical studies for regenerative medicine and tissue engineering
3.2.1.3. Increasing tissue engineering research funding
3.2.2. Market restraint analysis
3.2.2.1. High cost of product development
3.2.2.2. Ethical concerns related to stem cell research & tissue engineered product
3.3. U.S. Tissue Engineering Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Threat of new entrant
3.3.1.2. Threat of substitues
3.3.1.3. Bargaining power of buyers
3.3.1.4. Bargaining power of suppliers
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Tissue Engineering Market: Application Estimates & Trend Analysis
4.1. U.S. Tissue Engineering Market: Application Dashboard
4.2. U.S. Tissue Engineering Market: Application Movement Analysis
4.3. U.S. Tissue Engineering Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4. Cord Blood & Cell Banking
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Cancer
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. GI, Gynecology
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Dental
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Skin & Integumentary
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Urology
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Orthopedics, Musculoskeletal, & Spine
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Neurology
4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Cardiology & Vascular
4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.13. Others
4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company market share analysis, 2023
5.3.4. Zimmer Biomet Holdings, Inc.
5.3.4.1. Company overview
5.3.4.2. Financial performance
5.3.4.3. Product benchmarking
5.3.4.4. Strategic initiatives
5.3.5. AbbVie (Allergan)
5.3.5.1. Company overview
5.3.5.2. Financial performance
5.3.5.3. Product benchmarking
5.3.5.4. Strategic initiatives
5.3.6. Becton Dickinson and Company
5.3.6.1. Company overview
5.3.6.2. Financial performance
5.3.6.3. Product benchmarking
5.3.6.4. Strategic initiatives
5.3.7. B. Braun
5.3.7.1. Company overview
5.3.7.2. Financial performance
5.3.7.3. Product benchmarking
5.3.7.4. Strategic initiatives
5.3.8. Integra LifeSciences Corporation
5.3.8.1. Company overview
5.3.8.2. Financial performance
5.3.8.3. Product benchmarking
5.3.8.4. Strategic initiatives
5.3.9. Organogenesis Holdings Inc.
5.3.9.1. Company overview
5.3.9.2. Financial performance
5.3.9.3. Product benchmarking
5.3.9.4. Strategic initiatives
5.3.10. Medtronic
5.3.10.1. Company overview
5.3.10.2. Financial performance
5.3.10.3. Product benchmarking
5.3.10.4. Strategic initiatives
5.3.11. ACell, Inc.
5.3.11.1. Company overview
5.3.11.2. Financial performance
5.3.11.3. Product benchmarking
5.3.11.4. Strategic initiatives
5.3.12. Athersys, Inc.
5.3.12.1. Company overview
5.3.12.2. Financial performance
5.3.12.3. Product benchmarking
5.3.12.4. Strategic initiatives
5.3.13. Tissue Regenix Group plc
5.3.13.1. Company overview
5.3.13.2. Financial performance
5.3.13.3. Product benchmarking
5.3.13.4. Strategic initiatives
5.3.14. Stryker Corporation
5.3.14.1. Company overview
5.3.14.2. Financial performance
5.3.14.3. Product benchmarking
5.3.14.4. Strategic initiatives
5.3.15. RTI Surgical, Inc.
5.3.15.1. Company overview
5.3.15.2. Financial performance
5.3.15.3. Product benchmarking
5.3.15.4. Strategic initiatives
5.3.16. ReproCell, Inc.
5.3.16.1. Company overview
5.3.16.2. Financial performance
5.3.16.3. Product benchmarking
5.3.16.4. Strategic initiatives
5.3.17. Baxter International, Inc.
5.3.17.1. Company overview
5.3.17.2. Financial performance
5.3.17.3. Product benchmarking
5.3.17.4. Strategic initiatives
List of Tables
Table 1. List of abbreviations
Table 2. U.S. Tissue Engineering Market, by Application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 U.S. tissue engineering market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. tissue engineering market: Application outlook and key takeaways
Fig. 16 U.S. tissue engineering market: Application movement analysis
Fig. 17 Cord blood & cell banking market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 GI, gynecology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Dental market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Skin & integumentary market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Urology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Orthopedics, musculoskeletal, & spine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Cardiology & vascular market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Company market share analysis, 2023
Fig. 28 Strategic framework
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
